BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information letter on Carmubris powder and solvent for solution for infusion: incorrect labeling

Active substance: carmustine

The company TILLOMED PHARMA GmbH informs about an incorrect labeling of three batches of the medicinal product Carmubris powder and solvent for solution for infusion. The secondary packaging and the label of the vial containing the solvent state 10 ml instead of 3 ml. In fact, the vial contains the correct 3 ml of anhydrous ethanol, as described in the patient information leaflet and the summary of product characteristics.

Download risk information , Download_VeroeffentlichtAm_EN PDF, 443KB, File does not meet accessibility standards